Cara Therapeutics Reports Second Quarter 2019 Financial Results
The Company received net proceeds of approximately $136.4 million after deductions.
Read More
Select Page
Posted by Invest In Weed | Aug 7, 2019
The Company received net proceeds of approximately $136.4 million after deductions.
Read MorePosted by Invest In Weed | Aug 7, 2019
The company announced that its financial results for the second quarter 2019 will be available on Wednesday, August 14, 2019.
Read MorePosted by Invest In Weed | Aug 7, 2019
Dr. Chung and Mrs. Goldin bring a wealth of expertise and insights to CURE.
Read MorePosted by Invest In Weed | Aug 7, 2019
WeedMD increased its net revenues quarter-over-quarter by more than 140% to $8 million.
Read MorePosted by Invest In Weed | Aug 6, 2019
Record quarterly revenue Increased retail distribution by over 1,200 stores.
Read MoreGet stock alerts, news & related alerts straight to your inbox!